Nucleic Acid Isolation & Purification Market

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

Report Code: BT 2398 Jun, 2022, by marketsandmarkets.com

The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market.

As the world becomes more connected, collaboration and cooperation are needed to reduce the impact of future epidemics. To reduce the risk of future epidemics, increasing research is being conducted across the globe. For instance, the National Institutes of Health (US) invests USD 40 billion annually in health innovation and is expected to spend billions more on COVID- 19 research. Similarly, the UK government has decided to increase its R&D spending over the next three years to reach USD 28.82 billion (GBP 22 billion) by 2024–25. Countries in Asia, such as China and India, have also increased investments in their healthcare and pharmaceutical sectors.

Nucleic Acid Isolation & Purification Market

To know about the assumptions considered for the study, Request for Free Sample Report

Nucleic Acid Isolation And Purification Market Growth Dynamics

Drivers: How growth of nucleic acid isolation and purification market is related to the rising R&D activities in the genomic field?

The market is a research-driven sector. Pharmaceutical and biotechnology companies, being an integral part of the life science industry, invest heavily in research to develop breakthrough molecules to meet the growing needs of the healthcare sector. Moreover, the impending patent cliff has also led to an increase in the research activities of biopharmaceutical companies. Companies operating in the kits, reagents, and instruments market also increased their R&D investments to develop innovative products to meet the research requirements of the pharmaceutical and biotechnology industry. For instance, Thermo Fisher Scientific increased its R&D investments from USD 967 million in 2020 to USD 1,003 million in 2021. Similarly, Merck KGaA’s Life Sciences segment, which offers nucleic acid isolation and purification products, increased its R&D investments from USD 296.4 million in 2020 to USD 309.4 million in 2021.

Restraints: Does the high cost of analytical instrumets pose an obstacle in the growth of nucleic acid isolation and purification market?

Nucleic acid isolation and purification using kits and automated instruments are relatively more expensive than conventional methods. Automated instruments offer significant benefits like simplifications in isolation processes, reductions in working times, increased safety, and higher throughput. However, the high cost of these instruments limits their adoption. The cost of automated instruments for NAIP ranges from USD 8,000 to USD 160,000. These instruments are also associated with additional expenses for reagents, disposables, and maintenance and training. Institutes and companies with smaller R&D budgets cannot afford these expensive instruments.

Challenges: How is the changing regulatory and reimbursement scenario affecting nucleic acid isolation and purification market?

Despite the favourable funding scenario for personalized/precision medicine, the lack of reimbursement for diagnostic tests for precision medicine was a bottleneck for the adoption of NGS technologies for diagnostics. In the US, a coding and reimbursement structure was not adopted by the US CMS for reimbursement until early 2018, as NGS-based clinical practices were considered experimental. However, with the launch of advanced NGS products for diagnostic applications and rising awareness about the diagnostic applications of NGS, the CMS considered NGS a reasonable and necessary diagnostic laboratory test and, in March 2018, determined it to be covered nationally when ordered by a treating physician and performed in a CLIA-certified laboratory in the case of recurrent, relapsed, refractory, metastatic, or stage III or IV cancer, and other formulated criteria. Additionally, in April 2021, the FDA provided final guidance to streamline the submission and review of NGS-based tests and provide a flexible regulatory approach to allow the evolution of its standards with technological advancements in the field of NGS.

The kits segment accounted for the largest share of the nucleic acid isolation and purification market, by product, in 2021

Based on product, the market is segmented into kits, reagents, and instruments. In 2021, kits accounted for the largest share of the market. Growth in this market can be attributed to the wide-scale application of kits and reagents for DNA and RNA isolation for preparing samples and libraries, and the low cost and easy usage of kits. Also, a rising number of research studies focused on understanding rare and common genome-based diseases are increasingly using kits and reagents, which is further driving the segment. On the other hand, the instruments segment is expected to register the highest CAGR during the forecast period. The growth in the segment can be attributed to the launch of new instruments facilitating automation, rapid technological innovation, and growing demand for automated nucleic acid isolation and purification instruments.

By method, the column-based isolation and purification segment accounted for the largest market share in 2021.

On the basis of method, the market is segmented into column-based isolation and purification, magnetic bead-based isolation and purification, reagent-based isolation and purification, and other isolation and purification methods. In 2021, the column-based isolation and purification segment accounted for the largest share of the global market. Silica columns are extensively preferred for obtaining higher quality nucleic acids in a short time. In addition, these techniques can be incorporated in microchips and spin columns that have several advantages such as cost-effectivity, fast organic extraction, and compatibility with automated instruments. Hence, such methods are widely adopted in nucleic acid isolation methods.

By application, the diagnostics segment is expected to register the highest CAGR during the forecast period.

Based on application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications. The diagnostics segment accounted for the largest share of the global market; this segment is also expected to register the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to the growing awareness of genomic diagnostics among patients and the increasing efficiency of genomics sequencing in the diagnosis of diseases

By end user, the hospitals & diagnostic centers accounted for the largest market share in 2021.

On the basis of end user, the nucleic acid isolation and purification market is segmented into hospitals & diagnostic centers, academic & government research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users. In 2021, the hospitals & diagnostic centers segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing research activities and the use of nucleic acid tests in molecular diagnostics. DNA/RNA isolation and purification techniques are considered efficient tools for the diagnosis of even genetic diseases such as sickle cell anemia, hemophilia A, and Tay-Sachs disease. Hence, the availability of such efficient technologies at moderate to low prices is expected to increase their adoption rate in diagnostic centers and hospitals.

North America dominated the nucleic acid isolation and purification market, by region, in 2021

North America accounted for the largest share of the market in 2021. Factors such as presence of established players and their efforts in developing technologically advanced rapid purification and isolation devices is the major contributor to market growth in the region. In addition, the rising funding initiatives for biotechnology research are further propelling the growth of the market in the region. On the other hand, the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. The factors contributing to the growth of the market in the region include rising economic growth, extensive research in life sciences, growing patient population, supportive government initiatives, and the presence of various innovative biotech companies in the region.

Nucleic Acid Isolation & Purification Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Nucleic Acid Isolation & Purification Market Key Players

The prominent players in this market are QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Merck KGaA (Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), and Omega Bio-tek (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD)

Segments covered

Product, method, type, application, end user, and region

Geographies covered

North America, Europe, Asia Pacific, and the Rest of the World

Companies covered

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Promega
Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE
Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH
(Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany)

The research report categorizes the nucleic acid isolation and purification market into the following segments and subsegments:

By Product

  • Kits
  • Reagents
  • Instruments

By Type

  • Plasmid DNA Isolation and Purification
  • Total RNA Isolation and Purification
  • Circulating Nucleic Acid Isolation and Purification
  • Genomic DNA Isolation and Purification
  • Messenger RNA Isolation and Purification
  • microRNA Isolation and Purification
  • PCR Cleanup
  • Other Nucleic Acid Isolation and Purification Types

By Method

  • Column-based Isolation and Purification
  • Magnetic Bead-based Isolation and Purification
  • Reagent-based Isolation and Purification
  • Other Isolation and Purification Methods

By Application

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Agriculture & Animal Research
  • Other Applications

By End User

  • Hospitals & Diagnostic Centers
  • Academic & Government Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Recent Developments

:
  • In 2022, Thermo Fisher invested USD 97 million to expand its clinical research operations in Richmond, Virginia. The facility will provide high-quality bioanalytical lab services to advance clinical research programs.
  • In 2021, Thermo acquired PPD, a leading global provider of clinical research services to the biopharma and biotech industry, advancing its clinical research services.
  • In 2020, Merck invested EUR 18 million (USD 21.09 million) to build a life sciences laboratory in Buchs, Switzerland, to accelerate and support research & development, analytical production, and quality control.
  • In 2020, Thermo Fisher acquired QIAGEN N.V., a leading global provider of molecular diagnostics and sample preparation technologies. This acquisition is expected to expand the company’s specialty diagnostics portfolio with innovative sample preparation, assay, and bioinformatics technologies.
  • In 2018, Agilent acquired Advanced Analytical Technologies, a provider of capillary electrophoresis-based (CE) solutions for the fully automated analysis of a range of molecules.

Frequently Asked Questions (FAQs)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 28)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primary sources
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
           FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC (2021)
    2.3 MARKET GROWTH RATE PROJECTIONS
           FIGURE 6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTION
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ESTIMATION
    2.6 ASSUMPTIONS FOR THE STUDY
    2.7 LIMITATIONS FOR RESEARCH

3 EXECUTIVE SUMMARY (Page No. - 42)
    FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 MARKET, BY METHOD, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
           FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: MARKET, BY PRODUCT (2021)
           FIGURE 15 KITS TO DOMINATE NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2021
    4.3 GEOGRAPHICAL SNAPSHOT OF MARKET
           FIGURE 16 JAPAN TO WITNESS HIGHEST MARKET GROWTH RATE FROM 2022 TO 2027
    4.4 MARKET, BY REGION
           FIGURE 17 NORTH AMERICA TO DOMINATE MARKET IN 2027
    4.5 MARKET: DEVELOPED VS. DEVELOPING MARKETS
           FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE IN FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 53)
    5.1 Market Dynamics


           FIGURE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           5.1.1 DRIVERS
                    5.1.1.1 Increasing R&D activities
                    5.1.1.2 Technological advancements and increasing automation
           5.1.2 RESTRAINTS
                    5.1.2.1 High cost of automated instruments
           5.1.3 OPPORTUNITIES
                    5.1.3.1 High scope of growth in emerging economies
                    5.1.3.2 Improving regulatory and reimbursement scenario
                    5.1.3.3 Molecular diagnostics and personalized medicine
           5.1.4 TRENDS
                    5.1.4.1 Increase in government funding
    5.2 COVID-19 IMPACT ON THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
    5.3 PORTER’S FIVE FORCES ANALYSIS
           TABLE 1 PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT FROM NEW ENTRANTS
           5.3.2 THREAT FROM SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 DEGREE OF COMPETITION
    5.4 TECHNOLOGY ANALYSIS
    5.5 SUPPLY CHAIN ANALYSIS
           FIGURE 20 SUPPLY CHAIN ANALYSIS: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE (Page No. - 62)
    6.1 INTRODUCTION
           TABLE 2 MARKET, BY TYPE, 2019–2021 (USD MILLION)
           TABLE 3 MARKET, BY TYPE, 2022–2027 (USD MILLION)
    6.2 PLASMID DNA ISOLATION AND PURIFICATION
           6.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
                    TABLE 4 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 5 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
    6.3 TOTAL RNA ISOLATION AND PURIFICATION
           6.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH
                    TABLE 6 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 7 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
    6.4 GENOMIC DNA ISOLATION AND PURIFICATION
           6.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS
                    TABLE 8 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 9 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
    6.5 MESSENGER RNA ISOLATION AND PURIFICATION
           6.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS
                    TABLE 10 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 11 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
    6.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
           6.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
                    TABLE 12 MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 13 MARKET, BY REGION, 2022–2027 (USD MILLION)
    6.7 MICRORNA ISOLATION AND PURIFICATION
           6.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF RNA MOLECULES FROM SAMPLES
                    TABLE 14 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 15 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
    6.8 PCR CLEANUP
           6.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD
                    TABLE 16 PCR CLEANUP MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 17 PCR CLEANUP MARKET, BY REGION, 2022–2027 (USD MILLION)
    6.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES
           TABLE 18 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2019–2021 (USD MILLION)
           TABLE 19 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2022–2027 (USD MILLION)

7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD (Page No. - 77)
    7.1 INTRODUCTION
           TABLE 20 MARKET, BY METHOD, 2019–2021 (USD MILLION)
           TABLE 21 MARKET, BY METHOD, 2022–2027 (USD MILLION)
    7.2 COLUMN-BASED ISOLATION AND PURIFICATION
           7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION IS LARGEST SEGMENT OF MARKET
                    TABLE 22 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 23 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
    7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
           7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
                    TABLE 24 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 25 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
    7.4 REAGENT-BASED ISOLATION AND PURIFICATION
           7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH BETWEEN 2022 AND 2027
                    TABLE 26 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 27 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
    7.5 OTHER ISOLATION AND PURIFICATION METHODS
           TABLE 28 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2019–2025 (USD MILLION)
           TABLE 29 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2022–2027 (USD MILLION)

8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (Page No. - 84)
    8.1 INTRODUCTION
           TABLE 30 MARKET, BY PRODUCT, 2019–2021 (USD MILLION)
           TABLE 31 MARKET, BY PRODUCT, 2022–2027 (USD MILLION)
    8.2 KITS
           8.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2021
                    TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 33 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2022–2027 (USD MILLION)
    8.3 REAGENTS
           8.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD
                    TABLE 34 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 35 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
    8.4 INSTRUMENTS
           8.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS
                    TABLE 36 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 37 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2022–2027 (USD MILLION)

9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION (Page No. - 91)
    9.1 INTRODUCTION
           TABLE 38 MARKET, BY APPLICATION, 2019–2021 (USD MILLION)
           TABLE 39 MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
    9.2 DIAGNOSTICS
           9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET
                    TABLE 40 MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 41 MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2027 (USD MILLION)
    9.3 DRUG DISCOVERY & DEVELOPMENT
           9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS THERAPEUTIC AREAS
                    TABLE 42 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 43 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2027 (USD MILLION)
    9.4 PERSONALIZED MEDICINE
           9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE SEGMENT GROWTH
                    TABLE 44 MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 45 MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022–2027 (USD MILLION)
    9.5 AGRICULTURE & ANIMAL RESEARCH
           9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
                    TABLE 46 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2019–2021 (USD MILLION)
                    TABLE 47 MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2027 (USD MILLION)
    9.6 OTHER APPLICATIONS
           TABLE 48 MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2021 (USD MILLION)
           TABLE 49 MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2027 (USD MILLION)

10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER (Page No. - 101)
     10.1 INTRODUCTION
             TABLE 50 MARKET, BY END USER, 2019–2021 (USD MILLION)
             TABLE 51 MARKET, BY END USER, 2022–2027 (USD MILLION)
     10.2 HOSPITALS & DIAGNOSTIC CENTERS
             10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
                        TABLE 52 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2019–2021 (USD MILLION)
                        TABLE 53 MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2027 (USD MILLION)
     10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
             10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
                        TABLE 54 MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2021 (USD MILLION)
                        TABLE 55 MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022–2027 (USD MILLION)
     10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
             10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH
                        TABLE 56 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2021 (USD MILLION)
                        TABLE 57 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2027 (USD MILLION)
     10.5 CONTRACT RESEARCH ORGANIZATIONS
             10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
                        TABLE 58 MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2021 (USD MILLION)
                        TABLE 59 MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2027 (USD MILLION)
     10.6 OTHER END USERS
             TABLE 60 MARKET FOR OTHER END USERS, BY REGION, 2019–2021 (USD MILLION)
             TABLE 61 MARKET FOR OTHER END USERS, BY REGION, 2022–2027 (USD MILLION)

11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION (Page No. - 110)
     11.1 INTRODUCTION
             TABLE 62 MARKET, BY REGION, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA
             FIGURE 21 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
             TABLE 63 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 64 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 65 NORTH AMERICA: MARKET, BY METHOD, 2020–2027 (USD MILLION)
             TABLE 66 NORTH AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 67 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 68 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.2.1 US
                        11.2.1.1 Government and private funding to support market growth
                                     TABLE 69 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 70 US: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 71 US: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 72 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 73 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Growing investments in genomics to boost market demand
                                     TABLE 74 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 75 CANADA: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 76 CANADA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 77 CANADA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 78 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
     11.3 EUROPE
             TABLE 79 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 80 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 81 EUROPE: MARKET, BY METHOD, 2020–2027 (USD MILLION)
             TABLE 82 EUROPE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 83 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 84 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Germany to dominate market in Europe
                                     TABLE 85 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027
                                     TABLE 86 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 87 GERMANY: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 88 GERMANY: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 89 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 90 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 Government support for research through investments, funds, and grants to support market growth
                                     TABLE 91 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 92 UK: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 93 UK: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 94 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 95 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 High cancer burden to drive market growth
                                     TABLE 96 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 97 FRANCE: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 98 FRANCE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 99 FRANCE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 100 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.4 REST OF EUROPE
                        TABLE 101 REST OF EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 102 REST OF EUROPE: MARKET, BY METHOD, 2020–2027 (USD MILLION)
     11.4 ASIA PACIFIC
             FIGURE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
             TABLE 103 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 104 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 105 ASIA PACIFIC: MARKET, BY METHOD, 2020–2027 (USD MILLION)
             TABLE 106 ASIA PACIFIC: MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 107 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 108 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.1 CHINA
                        11.4.1.1 China is expected to register the highest growth in the nucleic acid isolation and purification market in the APAC
                                     TABLE 109 CHINA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 110 CHINA: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 111 CHINA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 112 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 113 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Various conferences & workshops are organized to explore various NAIP applications; a key factor driving market growth
                                     TABLE 114 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 115 JAPAN: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 116 JAPAN: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 117 JAPAN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 118 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Focused initiatives in the pharmaceutical & biotechnology industries to drive the market growth for NAIP in India
                                     TABLE 119 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 120 INDIA: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 121 INDIA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 122 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 123 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.4 REST OF ASIA PACIFIC (ROAPAC)
                        TABLE 124 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 125 ROAPAC: MARKET, BY METHOD, 2020–2027 (USD MILLION)
                        TABLE 126 ROAPAC: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 127 ROAPAC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 128 ROAPAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
     11.5 REST OF THE WORLD
             TABLE 129 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 130 ROW: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 131 ROW: MARKET, BY METHOD, 2020–2027 (USD MILLION)
             TABLE 132 ROW: MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 133 ROW: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 134 ROW: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.5.1 LATIN AMERICA
                        11.5.1.1 Increasing cancer cases to drive the demand for cancer diagnostic tests and, in turn, drive market growth for NAIP
                                     TABLE 135 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 136 LATIN AMERICA:  MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 137 LATIN AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 138 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 139 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.5.2 MIDDLE EAST & AFRICA
                        11.5.2.1 Lack of research infrastructure to restrict the growth of the NAIP market in this region
                                     TABLE 140 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 141 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                     TABLE 142 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 143 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 144 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
                                     TABLE 145 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 146 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 147 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 160)
     12.1 OVERVIEW
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 23 KEY DEVELOPMENTS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019-2022
     12.3 MARKET SHARE ANALYSIS
             FIGURE 24 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY KEY PLAYER, 2021
             TABLE 148 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEGREE OF COMPETITION
     12.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
           FIGURE 25 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019–2021
     12.5 COMPANY EVALUATION QUADRANT
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 26 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT, 2021
     12.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
     12.7 COMPANY FOOTPRINT ANALYSIS
             12.7.1 COMPANY PRODUCT FOOTPRINT
                        TABLE 149 COMPANY PRODUCT FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021)
     12.8 COMPANY REGIONAL FOOTPRINT
             TABLE 150 COMPANY REGIONAL FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021)
     12.9 COMPETITIVE SCENARIO
             TABLE 151 PRODUCT LAUNCHES
             TABLE 152 DEALS
             TABLE 153 OTHER DEVELOPMENTS

13 COMPANY PROFILES (Page No. - 171)
     13.1 MAJOR PLAYERS
(Business Overview, Products Offered,

Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 
             13.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 154 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                        FIGURE 28 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
             13.1.2 MERCK KGAA
                        TABLE 155 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2021)
             13.1.3 QIAGEN
                        TABLE 156 QIAGEN: BUSINESS OVERVIEW
                        FIGURE 30 QIAGEN: COMPANY SNAPSHOT (2021)
             13.1.4 F. HOFFMANN-LA ROCHE AG
                        TABLE 157 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
                        FIGURE 31 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021)
             13.1.5 GENERAL ELECTRIC COMPANY
                        TABLE 158 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
                        FIGURE 32 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)
             13.1.6 PROMEGA CORPORATION
                        TABLE 159 PROMEGA CORPORATION: BUSINESS OVERVIEW
             13.1.7 AGILENT TECHNOLOGIES, INC.
                        TABLE 160 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 33 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
             13.1.8 DANAHER CORPORATION
                        TABLE 161 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
             13.1.9 BIO-RAD LABORATORIES, INC.
                        TABLE 162 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
             13.1.10 ILLUMINA, INC.
                        TABLE 163 ILLUMINA, INC.: BUSINESS OVERVIEW
                        FIGURE 36 ILLUMINA, INC.: COMPANY SNAPSHOT (2021)
             13.1.11 TAKARA BIO, INC.
                        TABLE 164 TAKARA BIO, INC.: BUSINESS OVERVIEW
             13.1.12 NEW ENGLAND BIOLABS
                        TABLE 165 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
             13.1.13 OMEGA BIO-TEK, INC.
                        TABLE 166 OMEGA BIO-TEK, INC.: BUSINESS OVERVIEW
             13.1.14 NORGEN BIOTEK
                        TABLE 167 NORGEN BIOTEK: BUSINESS OVERVIEW
             13.1.15 ZYMO RESEARCH
                        TABLE 168 ZYMO RESEARCH: BUSINESS OVERVIEW
     13.2 OTHER COMPANIES
             13.2.1 GENAXXON BIOSCIENCE GMBH
                        TABLE 169 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW
             13.2.2 3D BLACKBIO BIOTECH INDIA LTD.
                        TABLE 170 3D BLACKBIO BIOTECH INDIA LTD.: COMPANY OVERVIEW
             13.2.3 INVITEK MOLECULAR GMBH
                        TABLE 171 INVITEK MOLECULAR GMBH: COMPANY OVERVIEW
             13.2.4 BIOVISION
                        TABLE 172 BIOVISION: COMPANY OVERVIEW
             13.2.5 ANALYTIK JENA AG
                        TABLE 173 ANALYTIK JENA AG: COMPANY OVERVIEW
*Details on Business Overview, Products Offered,
Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 

14 APPENDIX (Page No. - 230)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nucleic acid isolation and purification market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the nucleic acid isolation and purification market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents is provided below:

Nucleic Acid Isolation & Purification Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, method, type, application, end user, and region).

Data Triangulation

After arriving at the market size, the nucleic acid isolation and purification market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments.

Objectives of the Study

  • To define, describe, and forecast the global nucleic acid isolation and purification market by product, method, type, application, end user, and region
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, and opportunities)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nucleic acid isolation and purification market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the nucleic acid isolation and purification market in four major regions along with their respective key countries (North America, Europe, Asia Pacific, and the Rest of the World)
  • To profile the key players in the global nucleic acid isolation and purification market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, expansions, collaborations and R&D activities of the leading players in the nucleic acid isolation and purification market
  • To benchmark players within the nucleic acid isolation and purification market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the nucleic acid isolation and purification market into South Korea, New Zealand, and other Southeast Asian countries
  • Further breakdown of the European nucleic acid isolation and purification market into Italy, Spain, Belgium, and the Netherlands
Report Code
BT 2398
Published ON
Jun, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Nucleic Acid Isolation & Purification Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback